JP2022552834A5 - - Google Patents
Info
- Publication number
- JP2022552834A5 JP2022552834A5 JP2022521147A JP2022521147A JP2022552834A5 JP 2022552834 A5 JP2022552834 A5 JP 2022552834A5 JP 2022521147 A JP2022521147 A JP 2022521147A JP 2022521147 A JP2022521147 A JP 2022521147A JP 2022552834 A5 JP2022552834 A5 JP 2022552834A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- unsubstituted
- substituted
- formula
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962913417P | 2019-10-10 | 2019-10-10 | |
| US62/913,417 | 2019-10-10 | ||
| PCT/US2020/054896 WO2021072140A1 (en) | 2019-10-10 | 2020-10-09 | Prodrugs of myeloperoxidase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022552834A JP2022552834A (ja) | 2022-12-20 |
| JP2022552834A5 true JP2022552834A5 (https=) | 2023-04-18 |
Family
ID=75438074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521147A Pending JP2022552834A (ja) | 2019-10-10 | 2020-10-09 | ミエロペルオキシダーゼ阻害剤のプロドラッグ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240067651A1 (https=) |
| EP (1) | EP4041735A4 (https=) |
| JP (1) | JP2022552834A (https=) |
| KR (1) | KR20220080133A (https=) |
| CN (1) | CN114945573A (https=) |
| AU (1) | AU2020363903A1 (https=) |
| BR (1) | BR112022006381A2 (https=) |
| CA (1) | CA3157260A1 (https=) |
| IL (1) | IL291891A (https=) |
| MX (1) | MX2022004203A (https=) |
| WO (1) | WO2021072140A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021178734A1 (en) * | 2020-03-05 | 2021-09-10 | Biohaven Therapeutics Ltd. | Method of treating amyotrophic lateral sclerosis with myeloperoxidase inhibitor |
| CN115403584B (zh) * | 2021-05-26 | 2024-04-02 | 长春金赛药业有限责任公司 | 2-硫代-2,3-二氢嘧啶-4-酮衍生物、药物组合物及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5436790A (en) * | 1989-04-19 | 1990-11-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Sulfer-containing xanthine derivatives as adenosin antagonists |
| MY140748A (en) * | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| WO2007069924A1 (en) * | 2005-12-15 | 2007-06-21 | Industrial Research Limited | Deazapurine analogs of 4'-aza-l-nucleosides |
| NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
| US20090054468A1 (en) * | 2007-08-23 | 2009-02-26 | Astrazeneca Ab | New Use 938 |
| ES2691671T3 (es) * | 2010-06-24 | 2018-11-28 | Alkermes Pharma Ireland Limited | Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato |
| JP6667092B2 (ja) * | 2014-08-11 | 2020-03-18 | ハイドラ・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーＨｙｄｒａ Ｂｉｏｓｃｉｅｎｃｅｓ， ＬＬＣ | ピロロ［３，２−ｄ］ピリミジン−２，４（３Ｈ，５Ｈ）−ジオン誘導体 |
| WO2016140879A1 (en) * | 2015-03-03 | 2016-09-09 | Biohaven Pharmaceutical Holding Company Ltd. | Riluzole prodrugs and their use |
| AU2018304508B2 (en) * | 2017-07-17 | 2021-06-10 | Astrazeneca Ab | MPO inhibitors for use in medicine |
-
2020
- 2020-10-09 CA CA3157260A patent/CA3157260A1/en active Pending
- 2020-10-09 KR KR1020227015015A patent/KR20220080133A/ko not_active Withdrawn
- 2020-10-09 AU AU2020363903A patent/AU2020363903A1/en not_active Abandoned
- 2020-10-09 CN CN202080070666.8A patent/CN114945573A/zh active Pending
- 2020-10-09 MX MX2022004203A patent/MX2022004203A/es unknown
- 2020-10-09 JP JP2022521147A patent/JP2022552834A/ja active Pending
- 2020-10-09 EP EP20874337.7A patent/EP4041735A4/en not_active Withdrawn
- 2020-10-09 US US17/766,539 patent/US20240067651A1/en not_active Abandoned
- 2020-10-09 WO PCT/US2020/054896 patent/WO2021072140A1/en not_active Ceased
- 2020-10-09 IL IL291891A patent/IL291891A/en unknown
- 2020-10-09 BR BR112022006381A patent/BR112022006381A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022095872A5 (https=) | ||
| JP2022542222A5 (https=) | ||
| JP2019043957A5 (https=) | ||
| JP4664591B2 (ja) | 加水分解に安定な自己エッチングかつ自己下塗り用接着剤 | |
| RU2006143664A (ru) | Соединения для ингибирования ферментов | |
| JP2022552834A5 (https=) | ||
| JP2022546609A5 (https=) | ||
| JP2005514338A5 (https=) | ||
| IL276322B1 (en) | Lipid-like nanocomplexes and their uses | |
| JP2012529433A5 (https=) | ||
| CA2389681A1 (en) | Npy y5 antagonist | |
| RU2014137107A (ru) | Пептидомиметические макроциклы | |
| JP2013511554A5 (https=) | ||
| JP2008509166A5 (https=) | ||
| CA2750413A1 (en) | Hydroxamic acid derivatives | |
| DE69912952D1 (en) | Cyclosporine | |
| JP2016153410A5 (https=) | ||
| KR970042553A (ko) | 캠프토테신 유도체 | |
| JP2019509280A5 (https=) | ||
| RU2008126305A (ru) | Новый пептид | |
| WO2006010641A3 (en) | Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
| RU2004127136A (ru) | Способ получения гамма-амидов глутамовой кислоты | |
| JP2024532465A5 (https=) | ||
| CN114685646B (zh) | 一种多肽侧链类似物的制备方法及其应用 | |
| JP2021513990A5 (https=) |